Table 3.

Clinical outcomes after post-transplant relapse

	Remission			One year Survival
	CR rate (%)	95% CI	p-value	1-year Survival rate (%)	95% CI	p-value
Total	25	(17–34)		22	(15–31)
Donor type			.16			.36
RD	35	(19–53)		28	(14–44)
UCB	21	(12–32)		19	(11–29)
Treatment type			< .01			< .01
Intensive	44	(30–59)		37	(24–50)
Chemotherapy	28	(13–47)		35	(18–52)
DLI	58	(28–85)		50	(21–74)
2nd AlloHCT	73	(39–94)		27	(7–54)
Supportive	8	(2–22)		11	(3–23)
Time to Relapse			.03			.12
<6 months	20	(10–34)		21	(12–32)
≥6 months	41	(26–58)		24	(13–38)